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BACKGROUND: Obsessive-compulsive disorder (OCD) is a prevalent neuropsychiatric condition, with biological
models implicating disruption of cortically mediated inhibitory control pathways, ordinarily serving to regulate our
environmental responses and habits. The aim of this study was to evaluate inhibition-related cortical dysconnectivity
as a novel candidate vulnerability marker of OCD.
METHODS: In total, 20 patients with OCD, 18 clinically asymptomatic ﬁrst-degree relatives of patients with OCD, and
20 control participants took part in a neuroimaging study comprising a functional magnetic resonance imaging stop
signal task. Brain activations during the contrasts of interest were cluster thresholded, and a three-dimensional
watershed algorithm was used to decompose activation maps into discrete clusters. Functional connections
between these key neural nodes were examined using a generalized psychophysiological interaction model.
RESULTS: The three groups did not differ in terms of age, education level, gender, IQ, or behavioral task parameters.
Patients with OCD exhibited hyperactivation of the bilateral occipital cortex during the task versus the other groups.
Compared with control participants, patients with OCD and their relatives exhibited signiﬁcantly reduced connectivity
between neural nodes, including frontal cortical, middle occipital cortical, and cerebellar regions, during the stop
signal task.
CONCLUSIONS: These ﬁndings indicate that hypoconnectivity between anterior and posterior cortical regions during
inhibitory control represents a candidate vulnerability marker for OCD. Such vulnerability markers, if found to
generalize, may be valuable to shed light on etiological processes contributing not only to OCD but also obsessive-
compulsive–related disorders more widely.
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https://doi.org/10.1016/j.bpsc.2019.09.010Obsessive-compulsive disorder (OCD) constitutes a global
public health concern (1–3) and has been estimated to affect
2% to 3% of the population worldwide (4,5). Family and twin
studies have provided strong evidence of a heritable contri-
bution to the disorder (6), yet attempts to identify speciﬁc
genetic loci have met with only partial success. For example,
particular single nucleotide polymorphisms regulating cortical
(especially serotonergic and dopaminergic) neurotransmission
have been implicated in OCD, but inconsistently and typically
with individually small effect sizes (7). It has been proposed
that such limitations may be overcome in the future by using
intermediate biomarkers such as those combining imaging and
cognition (8–11). Fundamentally, OCD can be considered as
the mechanistic end point of underlying psychological and
brain processes (12). Intermediate-level, biologically grounded
vulnerability markers for OCD are lacking. By identifying latent
vulnerability markers (phenotypes) linked with underpinning
psychological processes contributing to a range of relatedª 2019 Society of Biological Psychiatry. Published by Elsevier Inc.
CC BY license (http://creativecommons.org/licenses/by/4.0/).
ical Psychiatry: Cognitive Neuroscience and Neuroimaging Februarymental disorders, new insights may be gleaned into underlying
causal mechanisms, including genetic ones, cutting across
conventionally discrete obsessive-compulsive and related
disorders (13,14).
In prior work, it was suggested that objective measures of
loss of inhibitory control constitute candidate latent pheno-
types for OCD (15). Deﬁcits on neuropsychological tasks of
motor inhibition, including the stop signal task (SST) (16,17),
have been observed in patients with OCD versus control par-
ticipants, as now also shown by a meta-analysis (18). These
deﬁcits have also been found in clinically asymptomatic ﬁrst-
degree relatives of patients with OCD in several studies
(16,19), highlighting their potential value as intermediate
phenotypic markers of vulnerability. Cortico-subcortical cir-
cuits have been centrally implicated in OCD symptomatology
(20). While initial OCD models focused on the prefrontal cortex,
recent data implicate other cortical regions and the cerebellum
in their pathophysiology (11,21–24). In a recent meta-analysisThis is an open access article under the
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ciated with hypoactivation during inhibitory control tasks in the
anterior cingulate cortex, anterior insula/frontal operculum,
supramarginal gyrus, orbitofrontal cortex, and thalamus/
caudate (25). The SST is contingent on frontal lobe integrity
and activates a distributed neural network, including frontal but
also posterior brain regions (26–28). This task has been found
to exhibit abnormal activation in patients with OCD and their
clinically unaffected ﬁrst-degree relatives (29) and so may be
valuable for addressing connectivity vulnerability markers of
the disorder.
While functional imaging has been widely used to explore
case-control differences in brain activation in OCD
(16,21,25,30,31), subsequent research has also elicited differ-
ences in the functional connectivity between different cortical
regions. In a meta-analysis of seed-based resting-state func-
tional imaging studies, OCD was associated with hypo-
connectivity between frontoparietal (executive), salience, and
default mode networks (22). Using the Multi-Source Interfer-
ence task, which examines aspects of cognitive control, a prior
study found altered regional connectivities in patients with OCD
compared with control participants, including in paralimbic,
sensorimotor, and default mode networks (32). In a functional
imaging study using an SST, (33), abnormal negative coupling
was found in patients with OCD versus control participants
between the inferior frontal gyrus and amygdala. Similar results
were evident, but to a lesser degree, in ﬁrst-degree relatives of
patients versus control participants (33).
The aim of this study therefore was to examine brain dys-
connectivity during response inhibition as a candidate latent
vulnerability marker for OCD. We hypothesized that patients
with OCD and their clinically asymptomatic ﬁrst-degree rela-
tives would exhibit reduced connectivity between frontal and
posterior brain regions within the inhibitory control network.
METHODS AND MATERIALS
Participants
Patients with OCD were recruited from a National Health
Service treatment center in the United Kingdom. Each patient
entering into the study gave permission for the study team to
contact a ﬁrst-degree relative (by preference this was a same-
gendered, similarly aged sibling when possible). Healthy con-
trol participants were recruited using media advertisements.
Participants provided written informed consent after having the
opportunity to read the information sheets and ask questions
of the study team. The study was approved by the Cambridge
Research Ethics Committee.
All study participants participated in an extended clinical
interview supplemented by the Mini International Neuropsy-
chiatric Interview (MINI; DSM-IV/ICD-10 version) (34), the
Montgomery–Åsberg Depression Rating Scale (MADRS) (35),
and the National Adult Reading Test (36). The MINI version
used identiﬁes the following mental disorders: major depres-
sive disorder, dysthymia, suicidality, manic episodes, panic
disorder, agoraphobia, social phobia, posttraumatic stress
disorder, alcohol dependence/abuse, substance dependence/
abuse, psychotic disorders, anorexia nervosa, bulimia nervosa,
generalized anxiety disorder, and antisocial personality disor-
der. The MADRS rates depressive symptoms, and the NationalBiological Psychiatry: Cognitive Neuroscience and NeurAdult Reading Test estimates IQ. For patients with OCD,
symptom severity was assessed via interview using the Yale-
Brown Obsessive-Compulsive Scale (37).
Inclusion criteria across all groups were being of adult age,
being right-handed according to the Edinburgh Handedness
Inventory (38), and being willing to provide written informed
consent. Exclusion criteria across all groups were the inability
to tolerate scanning procedures (e.g., owing to history of
claustrophobia), contraindication to scanning (e.g., metallic
implant, pregnancy), current depression (deﬁned as those in-
dividuals meeting DSM criteria on the MINI and/or those with
an MADRS score .15), current mental health disorder on the
MINI (except OCD in the OCD group), history of neurologic
disorders (e.g., Tourette’s syndrome, tics, major head trauma),
history of psychosis, and history of bipolar disorder. In the
OCD group, participants were required to meet DSM criteria for
the disorder based on clinical interview and the MINI, to have
primarily washing/checking symptoms, and to have a Yale-
Brown Obsessive-Compulsive Scale total score .16. Our
rationale for including patients with mainly washing/checking
symptoms was that washing symptoms in particular are
extremely common in OCD (5), and we wished to include the
same symptom-related criteria as in our previous case-
relative-control behavioral study (19). Patients with OCD with
clinically signiﬁcant hoarding were excluded because hoarding
differs from mainstream OCD and is now listed separately from
OCD in diagnostic nosological systems (39). In the OCD rela-
tives group and control group, participants were required to be
free from history of OCD (including no clinically signiﬁcant
symptoms based on extended clinical assessment such as the
MINI), to be free from other mainstream mental disorders (e.g.,
mood disorder, anxiety disorder), and to not be receiving
psychotropic medication(s).Stop Signal Task
Participants completed pretraining on the SST (40) prior to
functional magnetic resonance imaging (fMRI), with a view to
minimizing between-group differences in behavioral measures
that can confound interpretation of imaging connectivity data.
Participants then completed the task during fMRI. We used a
version of the task optimized for fMRI as described elsewhere
(41). In brief, individuals viewed a series of left- and right-
pointing arrows (the go signals) and were instructed to
respond as quickly as possible by clicking the button with their
right hand, depending on which direction the arrow was
pointing. Intermittently, a down-pointing arrow (the stop signal)
would appear on the screen for a variable time interval (initially
200 ms) after a go signal, and participants were instructed to
stop their initiated response when it appeared. By modulating
the go–stop gap as previously described, the task was
designed for a 50% successful inhibition outcome and was
performed by each participant for approximately 8 minutes.
The stop signal reaction time was calculated using the simple/
standard way for such designs, that is, by subtracting the
mean go–stop interval from the mean reaction time. Scanner
behavioral data recorded for each participant are presented in
the Supplement, with analyses indicating that the task design
functioned correctly [no behavioral differences between
groups and p(inhibit) close to 50% in each group as expected].oimaging February 2020; 5:222–230 www.sobp.org/BPCNNI 223
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Imaging data were acquired at the Wolfson Brain Imaging
Centre at the University of Cambridge. Participants were
scanned with a 3T Siemens TIM Trio scanner (Siemens Corp.,
Erlangen, Germany). While the participants were undertaking
the SST, blood oxygen level–dependent sensitive three-
dimensional volume images were acquired every 2 seconds.
The ﬁrst 10 images were discarded to account for equilibrium
effects of T1. Each image volume consisted of 32 slices of 4
mm thickness, with in-plane resolution of 3 3 3 mm and
orientated parallel with the anterior commissure–posterior
commissure line. A standard echo-planar imaging sequence
was used with 78 ﬂip angle, 30 ms echo time, and temporal
resolution of 1.1 seconds in a continuous descending
sequence. The ﬁeld of view of images was 192 3 192 mm, a
64 3 64 matrix, 0.51 ms echo spacing, and 2232 Hz/pixel
bandwidth. In addition, a 1-mm resolution magnetization pre-
pared rapid acquisition gradient-echo structural scan was
collected for each individual with a 256 3 240 3 192 matrix,
900 ms inversion time, 2.99 ms echo time, and 9 ﬂip angle.
Scan preprocessing was conducted using the standard pro-
cedure in SPM12. Data for each participant were motion cor-
rected, registered to the structural magnetization prepared
rapid acquisition gradient-echo, spatially warped onto the
standard Montreal Neurological Institute template using DAR-
TEL toolbox, upsampled to 2-mm cubed voxels, and spatially
smoothed using a Gaussian ﬁlter (8 mm full width at half
maximum Gaussian kernel).
General Linear Modeling Analysis
fMRI data were analyzed to determine blood oxygen level–
dependent signal changes in response to participants per-
forming the SST. General linear model analysis was applied at
the individual participant level in SPM12. The data were high-
pass ﬁltered (cutoff period = 180 seconds) to remove low-
frequency drifts in the MRI signal. Regressor functions for
each condition were created by convolving timing functions
indicating the onset of each of six event types, with a basis
function representing the canonical hemodynamic response.
The event types were successfully versus unsuccessfully
inhibited left or right responses and the left or right responses
in go trials. Six regressors were included representing rotations
and translations for the x-, y-, and z-axes.
Group-Level Analysis
Whole-brain maps depicting beta weights for the experimental
predictor functions from the ﬁrst-level models were collated for
group-level analyses using a full-factorial 2 3 2 3 3 design,
where outcome of the stop trials (successful inhibition or un-
successful inhibition) and the direction with which the
response was made were the within-subject factors and group
(OCD, relative, or control) was the between-subject factor. The
following four a priori voxelwise contrasts were estimated: 1)
the positive effect of condition (t contrast of the mean of all
stop trials vs. 0), which captures regions of the brain that are
signiﬁcantly active during stop trials; 2) successful minus failed
stop trials; 3) the main effect of group; and 4) the group 3
condition interaction. To correct for multiple comparisons
across the whole-brain mass, contrast images were224 Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Fthresholded at p , .05 voxelwise, and false discovery rate
cluster correction was then applied at p , .05. Signiﬁcant ef-
fects of group were further interpreted by ﬁtting 5-mm-radius
spheres at the peak coordinates of a given signiﬁcant F test
map and conducting post hoc permutation tests for each
groupwise comparison (10,000 permutations per test).
Regions of Interest
Regions of interest (ROIs) were generated by our in-house
three-dimensional watershed transform algorithm (42,43). The
method was used because it can accurately and efﬁciently
decompose thresholded statistical activation maps into
discrete clusters even when the clusters are contiguous. It was
conducted at the group level based on the thresholded sta-
tistical maps to enable connectivity across the activated
network to be examined. When generating the ROIs, the
within-subject contrasts (1 and 2) were also thresholded vox-
elwise at p, .01 to focus on the most active brain regions. The
ROIs formed the basis of the connectivity analyses.
Connectivity Analysis
Measures of task-evoked network connectivity were estimated
using psychophysiological interaction (PPI) models, which
quantify how the correlation in activity between pairs of brain
regions differs across task conditions. Notably, the classic PPI
method focuses on a single task contrast across task condi-
tions. More recently, a generalized form of PPI (gPPI) was
developed that simultaneously assesses the impact on con-
nectivity of multiple task conditions. We used a custom
MATLAB (The MathWorks, Inc., Natick, MA) implementation of
the following gPPI model:
YT ¼ b0 1 ½YS;HðXÞ;EbG 1 ½YS  HðXÞbj 1 e;
where X was the matrix containing psychological time courses
(i.e., time courses for encode, maintain, and probe events) and
HðXÞ was the hemodynamic response function convolution of
that matrix; YT was the target time series and YS was the
source time series; E was the nuisance regressor matrix
deﬁned previously in the preprocessing stage; bG included
weights of no interest and bj included the weights for the PPI
predictors, which were the target of further analysis; b0 was the
intercept and ewas the residual error. This model was esti-
mated for all pairs of connections to form a connectivity matrix,
and upper and lower triangles were averaged to form an un-
directed weighted connectivity matrix for each condition in the
design matrix. gPPI models included successful inhibition,
failed inhibition, and go trials for each participant group. Two
contrasts were generated: all stop signals minus all go trials
and successful minus failed stop signal trials. Mixed analyses
of variance were applied to test for signiﬁcant differences
among the three groups in the pattern of PPI estimates across
ROIs. Pairwise t tests were then applied at an uncorrected
p , .01 threshold to characterize the basis of any signiﬁcant
interactions.
RESULTS
In total, 20 patients with OCD, 18 of their nonsymptomatic
ﬁrst-degree relatives, and 20 control participants completedebruary 2020; 5:222–230 www.sobp.org/BPCNNI
Table 1. Demographic and Clinical Characteristics of Patients With Obsessive-Compulsive Disorder, Their Unaffected First-
Degree Relatives, and Healthy Control Participants
Patients
(n = 20)
Relatives
(n = 18)
Control Participants
(n = 20) Statistic p
Demographic Measures
Age, years 37.6 6 14.6 40.7 6 10.8 36.3 6 8.3 F2 = 0.7115 .4954
Gender, n (male:female) 20 (17:3) 18 (13:5) 20 (15:5) c22 = 1.007 .6044
NART IQ 115.4 6 5.2 114.6 6 7.2 115.9 6 6.2 Kruskal–Wallis statistic = 0.23 .8914
Clinical Measures
MADRS 7.5 6 7.5 2.33 6 3.3 1.30 6 3.4 Kruskal–Wallis statistic = 16.05 .0003
Y-BOCS obsessions 11.15 6 2.58 – – – –
Y-BOCS compulsions 11.85 6 2.62 – – – –
Y-BOCS total 22.50 6 5.30 – – – –
Values are presented as mean 6 standard deviation unless otherwise stated. One-way analysis of variance or Kruskal–Wallis statistical tests
were used depending on the normality of data.
MADRS, Montgomery–Åsberg Depression Rating Scale; NART, National Adult Reading Test; Y-BOCS, Yale-Brown Obsessive Compulsive Scale.
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are presented in Table 1, where it can be seen that the groups
were well matched on age, gender, and IQ. As expected, pa-
tients with OCD scored signiﬁcantly higher on MADRS total
scores than the other groups, but mean scores were well
below the threshold for clinically signiﬁcant depression, in
keeping with the exclusion criteria used. Task-related behav-
ioral measures did not differ signiﬁcantly among the groups
(see Supplement). The following numbers of patients were
taking psychotropic medication: eight selective serotonin re-
uptake inhibition monotherapy and two selective serotonin
reuptake inhibitor plus low-dose antipsychotic medication.
One patient was also taking occasional lorazepam but had not
taken this within 48 hours of study participation.
Activation Results for the SST
Activation differences for the SST contrasts of interest, along
with the extracted ROIs, are summarized in Figure 1 (all falseFigure 1. Signiﬁcant activation maps for the contrasts of interest during the stop
rate p, .05). (B) Brain regions activated during stop signal trials (false discovery ra
(false discovery rate p, .05). (D) Regions of interest for subsequent connectivity a
and color coded in keeping with (A) to (C). Ant, anterior; Inf, inferior; L, left; Mid, m
Biological Psychiatry: Cognitive Neuroscience and Neurdiscovery rate ps , .05). There was a main effect of group
(Figure 1A), yielding group differences mainly in the occipital
lobes, speciﬁcally in the left and right occipital cortex (Brod-
mann areas 18 and 19), the temporal occipital fusiform cortex
(Brodmann area 37), and the cerebellum. Post hoc permutation
tests indicated that the group effect was due to hyper-
activation in patients with OCD versus both other groups
maximal in the bilateral lateral occipital complex (both ps ,
.001) (Supplemental Figure S1). Brain regions signiﬁcantly
activated during stop signal trials, across all participants, are
shown in Figure 1B. It can be seen that the SST activated the
distributed inhibitory control network, including the bilateral
inferior frontal gyrus, insula, and anterior cingulate cortex. For
the contrast of successful minus failed stops across all par-
ticipants, relative hypoactivation was observed (Figure 1C) in
regions associated with motor responses (including Brodmann
areas 4 and 6). This is consistent with failed stops activating
relevant motor areas owing to action as compared with theresignal task. (A) Brain regions showing a main effect of group (false discovery
te p, .05). (C) Brain regions underactivated for successful minus failed stops
nalyses on a brain map and also labeled, generated from the above contrasts
iddle; Oper, operculum; Post, posterior; R, right; Sup, superior.
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of group 3 successful minus failed inhibition did not yield
signiﬁcant regions.
Group Differences in Connectivity for the SST
The 29 functional ROIs from the above activation maps
(Figure 1D) were used for the subsequent connectivity anal-
ysis. For the SST contrast (stop signal minus go trials), there
was no signiﬁcant main effect of group on gPPI connectivity
(F = 0.69, p = .50), there was a signiﬁcant effect of connection
(F = 1.78, p = .011), and there was no signiﬁcant interaction
(F = 1.17, p = .19) (all Greenhouse–Geisser corrected). When
applied to the success minus fail contrast, there was a sig-
niﬁcant main effect of group (F = 3.67, p = .032) and connec-
tion (F = 1.71, p = .016) and a signiﬁcant interaction (F = 1.38,
p = .041) (all Greenhouse–Geisser corrected). These results
indicated that the task conditions affected network connec-
tivity in different ways across the three groups. To characterize
the basis of the effects at the node level, the coefﬁcients were
contrasted pairwise for patients and their relatives versus
control participants, thresholded at p , .01 two tailed
(Figure 2). A widespread pattern of reduced connectivity was
evident in patients with OCD and their relatives. Summing the
number of supra-threshold connections for each node high-
lighted a high degree of abnormality affecting cerebellum area
crus 1 connectivity bilaterally, middle occipital gyrus bilaterally,
superior frontal gyrus and superior medial frontal cortex, left
middle temporal, and left postcentral gyri.
DISCUSSION
This study evaluated functional brain dysconnectivity during
response inhibition as a candidate vulnerability marker for
OCD. Consistent with our hypothesis, the key ﬁnding was that
patients with OCD and their ﬁrst-degree relatives had abnor-
mally reduced functional connectivity during the SST between
frontal and posterior brain regions, including the frontal cortex,
occipital cortex, and cerebellum. These novel ﬁndings accord
well with the notion that functional connectomics constitutes a
candidate vulnerability marker for OCD, supporting neurobio-
logical models of the disorder implicating loss of cortically
mediated inhibitory control, not only constrained to the frontal
lobes but also involving distant posterior brain regions (15,44).
Conventional analysis conﬁrmed that the fMRI SST acti-
vated neural circuitry, including the bilateral inferior frontal
cortex and anterior cingulate cortex as well as more posterior
parts of the brain playing a role in visual attention streams
(Figure 1). This is in keeping with prior lines of research
implicating such regions in cortically mediated motor inhibition
processes (26,45–47). We generated a set of ROIs using an
innovative watershed algorithm to examine connectivity dif-
ferences between groups using a gPPI model. This identiﬁed
widespread patterns of hypoconnectivity, common to patients
with OCD and their relatives, versus control participants in
frontal and posterior brain regions (Figure 2). Overall group
differences in connectivity during the SST were speciﬁcally
detected during the success–fail contrast, with connectivity
being lower in patients and relatives versus control partici-
pants. In the absence of signiﬁcant overall stop–go differences
in connectivity among the groups, this suggests that patients226 Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Fwith OCD and their relatives had higher connectivity for failed
stops and/or lower connectivity for successful stops compared
with control participants. Ultimately, determining what this
means on a process level requires further investigation
examining causal dynamics. However, the implicated neural
regions are likely to operate via mutual bidirectional connec-
tions to facilitate response inhibition (48). It is interesting to
note that certain frontal brain regions found to be abnormally
connected here during response inhibition (i.e., inferior frontal
cortex/insula) were previously found to exhibit reduced striatal-
related connectivity in OCD in association with cognitive
rigidity (49).
The most commonly dysconnected nodes common to pa-
tients and their asymptomatic ﬁrst-degree relatives included
frontal cortical, occipital, and cerebellar regions (Figure 2).
Conventional neurobiological models of OCD have focused on
the frontal lobes, whereas the current ﬁndings implicate
abnormal connections involving not only frontal brain regions
but also these other brain regions. This is in keeping with
several tiers of OCD research more broadly (21,24,50),
including connectivity studies. For example, resting-state
connectivity changes in OCD were maximal in the cerebellar
crus 1 region (51), and machine learning algorithms designed
to discriminate patients with OCD from control participants
based on resting-state connectivity indicated important con-
tributions from not only frontal regions but also occipital and
cerebellar regions (52). To our knowledge, only one previous
study has examined task-related functional dysconnectivity as
a candidate vulnerability marker for OCD (53). This study found
reduced functional connectivity between the right dorsolateral
prefrontal cortex and the basal ganglia (putamen) during ex-
ecutive planning (53). Resting-state connectivity changes have
also been described in the literature, in patients with OCD and
their relatives, involving distributed brain regions (54,55).
Collectively, the emerging evidence thus suggests important
dysconnectivity not only between cortical and subcortical re-
gions but also between anatomically distant cortical regions in
OCD, ﬁndings that are likely to be contingent on the nature of
the cognitive probe used to explore such neural circuitry.
In terms of group differences in SST-related brain activation
(as opposed to functional connectivity), we found differences
in posterior brain regions, maximal in the bilateral lateral oc-
cipital complex. This result was attributable to hyperactivation
in patients versus both other groups, whereas activation in
relatives did not differ from control participants in this region.
There was no group 3 successful minus failed inhibition
interaction, indicating that this abnormality was common to
inhibition trials on the task whether or not inhibition was suc-
cessful. The lateral occipital complex plays an important role in
visual attentional processing, including representation and
perception of objects (56) and faces (57). One interpretation of
the current ﬁnding is that hyperactivation of this visual pro-
cessing region may be related to hypervigilance in OCD or an
expectation of an environmental threat. Owing to the unpre-
dicted nature of this result, replication is required before ﬁrm
conclusions can be made. Nonetheless, this result suggests
that tasks designed to probe visual attentional streams may be
valuable in OCD research.
Although this is the ﬁrst study to address inhibitory control–
related functional connectivity as a candidate vulnerabilityebruary 2020; 5:222–230 www.sobp.org/BPCNNI
Figure 2. Results from connectivity analyses. (A) Schemaball showing abnormally hypoconnected regions in patients with obsessive-compulsive disorder
and relatives versus control participants. Each region of interest (ROI) is indicated by a peripheral label. Curved lines within the circle indicate ROI–ROI
connections that were signiﬁcantly hypoconnected in patients and relatives versus control participants. Thicker curved lines indicate greater abnormality
(mean psychophysiological interaction coefﬁcient). The outer circumference of the circle is color coded to indicate the contrast of interest as per Figure 1, and
the size of nodes on the peripheral circle represents the total number of suprathreshold abnormal connections (i.e., nodal degree). (B) Glass brain repre-
sentation of abnormal connections from (A) to show anatomical extents. (C) List of all ROIs and the number of suprathreshold connections with other regions
for each ROI. Color codings refer to the task contrasts of interest. AA, Automated Anatomical Labeling; Inf, inferior; L, left; Mid, middle; MNI, Montreal
Neurological Institute; Post, posterior; R, right; Sup, superior.
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CNNImarker for OCD, several limitations should be considered. We
recruited patients with primarily washing/checking OCD
symptoms who did not have comorbidities. As such, it remains
to be demonstrated whether the ﬁndings generalize to patients
with other primary symptoms or to those who have comor-
bidities. Owing to the sample size, power may be limited. Our
approach could be viewed as conservative because nodes of
interest were generated using false discovery rate p , .05;
hence, and in view of the sample size, some neural nodes
implicated in OCD, but with a smaller effect size, may have
been overlooked. Presupplementary motor activation abnor-
malities were previously found in patients with OCD and their
relatives (29), but we could not replicate this ﬁnding in the
relevant ROIs (see Supplemental Table S2). Likely because
participants were pretrained, they did not differ on stop signal
behavioral measures; this is an advantage because it simpliﬁes
imaging interpretation, but the corollary is that our study did
not measure neural changes related to impaired inhibition but
rather measured neural changes related to inhibition per se.
Owing to the nature of the gPPI analysis, it could not be
established whether there was heightened connectivity during
go trials or decreased connectivity during stop trials in the
patients and relatives. Our connectivity difference was in the
contrast of successful–failed stop trials. Control participants
showed heightened connectivity when stopping was suc-
cessful relative to unsuccessful. In OCD, this effect was
reduced. This is an interesting pattern of connectivity differ-
ence. Patients with OCD may be engaging the network more
during unsuccessful stop trials, in line with abnormal post-error
processing. Or, it may be that they engage the network less
during the successful stop trials. The fact that we see this
difference but no cross- group difference for stop–go suggests
that it is both. This aspect could be assessed in future studies
by including rest blocks, allowing activity and connectivity
during routine responding to be estimated separate from the
resting baseline. While some patients with OCD were receiving
psychotropic medications, functional dysconnectivity was also
found in these patients’ relatives who were not receiving any
psychotropic medications. Hence, while we cannot address
effects of such pharmacotherapies on connectivity owing to
the sample size, our key ﬁndings were not due to such effects.
Prior work found treatment-related changes in activation
during a Stroop task, which examines attentional inhibition
processes, in patients with OCD (58). Future work should
examine effects of treatment on functional connectivity during
inhibition tasks in OCD. We did not observe robust differences
between the OCD and ﬁrst-degree relative groups in functional
connectivity. Identiﬁcation of differences between these two
types of group using larger samples in future work may be
valuable to identify mechanisms associated with chronicity/
instantiation of OCD as opposed to vulnerability toward OCD.
Lastly, the current study focused on cortical functional con-
nectivity; however, given the prominent role of the basal
ganglia in OCD models, future work should also look at
cortico-subcortical connectivity on the SST, with there already
being evidence of abnormalities in OCD using an executive
planning task (53).
In conclusion, we found that hypoconnectivity during
response inhibition, involving frontal and posterior brain re-
gions, may constitute a candidate vulnerability marker for228 Biological Psychiatry: Cognitive Neuroscience and Neuroimaging FOCD. Future studies could use such cognitive probe connec-
tivity approaches to help delineate etiological factors involved
in OCD and extend research into other obsessive-compulsive–
related disorders (59).
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